
Home » LUPIN TO MARKET LUPENOX IN INDIA
LUPIN TO MARKET LUPENOX IN INDIA
India-based Lupin has entered into an agreement with ItalFarmaco, an Italian pharmaceutical company, to market the cardiovascular critical-care product Lupenox (Enoxaparin sodium injection) in the Indian market.
"Lupin has always made quality products affordable to Indian patients," said Satki Chakraborty, president for Indian-region formulations at Lupin. "Our tie-up with ItalFarmaco is yet another effort in this direction. In life critical situations, quality is of paramount importance."
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct